Indianapolis, IN, November 2, 2021 — Barbara Van Dahlen, PhD, has joined MindX Sciences as Chief Psychology Officer and co-chair of our Mental Health Transformation Advisory Board, along with Dr. Jerome Adams, the former Surgeon General of the United States. Dr. Van Dahlen was most recently the Executive Director of the US Government PREVENTS Task Force. Dr. Van Dahlen is also the Founder of Give an Hour nonprofit organization, and Mental Health Consultant to ABC’s A Million Little Things. She will provide leadership to our suicide prevention efforts, and strategic advice on new product development and roll-out.
Indianapolis, IN, October 1st, 2021 — MindX Sciences has been issued CPT codes for 6 blood tests (see pages 9-10).
Indianapolis, IN, September 28th, 2021 — Why biomarkers are going to revolutionize mental health. Dr. Niculescu's new piece in Neuropsychopharmacology.
Indianapolis, IN, August 6th, 2021 — Congratulations to our Board Member and co-founder Dr. Tien Lee. His company, Aardvark Therapeutics, closed series B.
Indianapolis, IN, July 14th, 2021 — The United States Patent Office granted US Patent No. 11,047,009 titled: BLOOD BIOMARKERS FOR SUICIDALITY, licensed by MindX Sciences from Indiana University.
Indianapolis, IN, June 3, 2021 — MindX Sciences has established a Mental Health Transformation Advisory Board, which will be led by Dr. Jerome Adams, the former Surgeon General of the United States. He will provide strategic advice on maximizing societal impact, addressing health disparities, and helping improve military mental health. Dr. Adams is also a practicing anesthesiologist, and has a strong interest and expertise in pain treatments and addictions.
A blood test may help the diagnosis and treatment of depression. The Economist — May 3, 2021
MindX Sciences Aims to Bring Objectivity to Psychiatric Disorder Testing With RNA Expression Markers. GenomeWeb — April 28, 2021
Panel of 26 Biomarkers May Allow for Precision Medicine Treatment Plans Among Patients With Mood Disorders. PsychiatryAdvisor — April 26, 2021
Indianapolis, April 26, 2021 — MindX Sciences is proud to announce a partnership with Q2, a premier genomics lab. View more...
Can a Blood Test Diagnose Depression? HealthyWomen — April 20, 2021
Researchers develop blood test that could help gauge depression, bipolar disorder. FOX5 New York — April 12, 2021
Bientôt un test sanguin pour détecter la dépression et le trouble bipolaire? Pourqui Docteur — 11.04.2021
Researchers Develop Biomarker Blood Test for Depression, Bipolar Disorder. Genetic Engineering & Biotechnology News — April 9, 2021
Indianapolis, IN, April 8th, 2021 — IU School of Medicine researchers develop blood test for depression, bipolar disorder. View more...
Indianapolis, IN, March 9th, 2021 — Dr. Christopher Reist, an authority on PTSD and clinical trials, joined the Scientific Advisory Board (SAB) of MindX Sciences.
Indianapolis, IN, March 8th, 2021 — Dr. Alexander Niculescu gave a talk on “Precision Medicine for Mood Disorders”, an upcoming publication, at the annual invitation-only Translational Psychiatry meeting in Park City, Utah, this year held in a virtual format.
Indianapolis, IN, February 26th, 2021 — The United States Patent Office granted US Patent No. 10,991,449 titled: PREDICTING SUICIDALITY USING A COMBINED GENOMIC AND CLINICAL RISK ASSESSMENT, licensed by MindX Sciences from Indiana University.
Can An Indy Startup Conquer Mental Health’s Final Frontier? Indianapolis Monthly, March 2021